Ivivi Technologies, Inc. News - II

Ivivi PEMF Technology Accelerates Wound Healing in Laboratory Animals, Study Reports

Ivivi Technologies, Inc.?s (AMEX: II) non-invasive, pulsed electromagnetic field (PEMF) technology increased tensile strength...

Ivivi Technologies Announces Completion of Patient Enrollment for its Cardiac Clinical Trial at The Cleveland Clinic Florida

Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technology, today announced that it has...

Ivivi Technologies Reports Fiscal 2007 Financial Results

Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, today announced financial results...

Ivivi Technologies Receives CE Approval for Certain of its Electrotherapy Devices

Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, today announced that it has...

Ivivi Technologies Issues 'Call for Papers' for Science of Electroceuticals(TM) Symposium

Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, announced today its ?Call for...

Ivivi to Release Fiscal 2007 and Fourth Quarter Results and Hold Conference Call on June 28, 2007

Ivivi Technologies, Inc. (AMEX: II), a leader in non-invasive, electrotherapeutic technologies, today announced that management...

Ivivi's PEMF Technology Significantly Improves Neuron Survival in Parkinson's Disease Model, Study Finds

Proprietary Pulsed Electromagnetic Field (PEMF) technology, developed by Ivivi Technologies, Inc. (AMEX:II), improved neuron...

Ivivi PEMF Technology Produces 80% Acceleration in Pain Relief in a Controlled Clinical Study Assessing Post-Surgical Pain

Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, today announced that preliminary...

Ivivi Technologies To Present At Brean Murray Carret & Co. Small-Cap Healthcare & Biotechnology One-on-One Conference

Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technology, today announced that Andre?...

Ivivi Technologies and Its Exclusive Canadian Distributor, T.H.E. Medical, Announce Health Canada Approval of Roma3 Electrothera

Ivivi Technologies, Inc. (AMEX:II), a developer of non-invasive, electrotherapeutic technologies, today announced that Barrie...

Ivivi PEMF Technology Provides a Non-Pharmacologic Approach for AHA Guidelines to Avoid NSAIDs for Patients at Risk for Heart Di

Ivivi Technologies, Inc. (AMEX:II), an innovator of non-invasive, electrotherapeutic technology, today commented on the recent...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ivivi Technologies, Inc. (II)

Empower your portfolio: Real-time discussions and actionable trading ideas.

II News

Ivivi PEMF Technology Accelerates Wound Healing in Laboratory Animals, Study Reports

Ivivi Technologies Announces Completion of Patient Enrollment for its Cardiac Clinical Trial at The Cleveland Clinic Florida

Ivivi Technologies Reports Fiscal 2007 Financial Results

Ivivi Technologies Receives CE Approval for Certain of its Electrotherapy Devices

Ivivi Technologies Issues 'Call for Papers' for Science of Electroceuticals(TM) Symposium

Ivivi to Release Fiscal 2007 and Fourth Quarter Results and Hold Conference Call on June 28, 2007

Ivivi's PEMF Technology Significantly Improves Neuron Survival in Parkinson's Disease Model, Study Finds

Ivivi PEMF Technology Produces 80% Acceleration in Pain Relief in a Controlled Clinical Study Assessing Post-Surgical Pain

Ivivi Technologies To Present At Brean Murray Carret & Co. Small-Cap Healthcare & Biotechnology One-on-One Conference

Ivivi Technologies and Its Exclusive Canadian Distributor, T.H.E. Medical, Announce Health Canada Approval of Roma3 Electrothera

Ivivi PEMF Technology Provides a Non-Pharmacologic Approach for AHA Guidelines to Avoid NSAIDs for Patients at Risk for Heart Di

Ivivi Technologies to Sponsor Science of Electroceuticals Symposium

Ivivi Technologies Reports Second Quarter Fiscal 2007 Financial Results

Ivivi Technologies Reports Second Quarter Fiscal 2007 Financial Results

Ivivi Technologies, Inc. Announces Exercise of Underwriters' Over-Allotment Option for 250,000 Shares of Common Stock

II Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ivivi Technologies, Inc. (II) News

Ivivi Technologies, Inc. (II)

Empower your portfolio: Real-time discussions and actionable trading ideas.

II News

Ivivi PEMF Technology Accelerates Wound Healing in Laboratory Animals, Study Reports

Ivivi Technologies Announces Completion of Patient Enrollment for its Cardiac Clinical Trial at The Cleveland Clinic Florida

Ivivi Technologies Reports Fiscal 2007 Financial Results

Ivivi Technologies Receives CE Approval for Certain of its Electrotherapy Devices

Ivivi Technologies Issues 'Call for Papers' for Science of Electroceuticals(TM) Symposium

Ivivi to Release Fiscal 2007 and Fourth Quarter Results and Hold Conference Call on June 28, 2007

Ivivi's PEMF Technology Significantly Improves Neuron Survival in Parkinson's Disease Model, Study Finds

Ivivi PEMF Technology Produces 80% Acceleration in Pain Relief in a Controlled Clinical Study Assessing Post-Surgical Pain

Ivivi Technologies To Present At Brean Murray Carret & Co. Small-Cap Healthcare & Biotechnology One-on-One Conference

Ivivi Technologies and Its Exclusive Canadian Distributor, T.H.E. Medical, Announce Health Canada Approval of Roma3 Electrothera

Ivivi PEMF Technology Provides a Non-Pharmacologic Approach for AHA Guidelines to Avoid NSAIDs for Patients at Risk for Heart Di

Ivivi Technologies to Sponsor Science of Electroceuticals Symposium

Ivivi Technologies Reports Second Quarter Fiscal 2007 Financial Results

Ivivi Technologies Reports Second Quarter Fiscal 2007 Financial Results

Ivivi Technologies, Inc. Announces Exercise of Underwriters' Over-Allotment Option for 250,000 Shares of Common Stock

II Discussion

Your Recent History